science PPP

Our chat with Dai Hayward, CEO at Micropore Technologies. Micropore has developed a globally award-winning technology which gives the precision of microfluid...

We interviewed Simon Saxby, CEO at Leaf Expression Systems. Leaf Expression Systems is an innovative contract development and manufacturing organisation spec...

Our chat with Dr Arron Tolley, CEO at Aptamer Group. Aptamer Group utilises high-throughput, in-vitro techniques to select aptamers that are engineered to bi...

We caught up with Chris Rogers, Global Sales and Marketing Director at Medovate. Medovate is an innovation development company dedicated to the commercialisa...

We caught up with Rowan Minkley, the CEO and Co-founder of Chip[s] Board, as part of ‘Product | People | Potential’. Chip[s] Board is dedicated...

We caught up with Caroline Barelle, the CEO of Elasmogen, as part of ‘Product | People | Potential’. Elasmogen is progressing next generation biologics for...

We caught up with Carolyn Porter, CEO at CytoSeek. CytoSeek is enabling the next generation of cell therapies through its artificial membrane-binding protein...

We caught up with Neciah Dorh, CEO and Founder of FluoretiQ. FluoretiQ is a rapid bacterial identification technology that can diagnose infection within minu...

We caught up with Gustaf Hemberg, Co-Founder & CEO of Scindo as part of ‘Product | People | Potential’. Scindo is creating a novel biological...

We caught up with Katie Critchlow, CEO of NatureMetrics, as part of ‘Product | People | Potential’. NatureMetrics use next generation sequencing to identify ...

We caught up with Orr Yarkoni, CEO of Colorifix, as part of ‘Product | People | Potential’. Colorifix uses synthetic biology to remove the need...

We caught up with Clarissa Sowemimo-Coker, General Counsel at Oxford Cannabinoid Technologies, and Valentino Parravicini, the Chief Scientific Officer. Oxfor...